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The differential expression of alleles occurs commonly in humans and is likely an important genetic factor underlying
heritable differences in phenotypic traits. Understanding the molecular basis of allelic expression differences is thus an
important challenge. Although many genes have been shown to display differential allelic expression, this is the first
study to examine in detail the cumulative effects of multiple cis-regulatory polymorphisms responsible for allele-
specific expression differences. We have used a variety of experimental approaches to identify and characterize cis-
regulatory polymorphisms responsible for the extreme allele-specific expression differences of keratin-1 (KRT1) in
human white blood cells. The combined data from our analyses provide strong evidence that the KRT1 allelic
expression differences result from the haplotypic combinations and interactions of five cis-regulatory single nucleotide
polymorphisms (SNPs) whose alleles differ in their affinity to bind transcription factors and modulate KRT1 promoter
activity. Two of these cis-regulatory SNPs bind transcriptional activators with the alleles on the high-expressing KRT1
haplotype pattern having a higher affinity than the alleles on the low-expressing haplotype pattern. In contrast, the
other three cis-regulatory SNPs bind transcriptional inhibitors with the alleles on the low-expressing haplotype pattern
having a higher affinity than the alleles on the high-expressing haplotype pattern. Our study provides important new
insights into the degree of complexity that the cis-regulatory sequences responsible for allele-specific transcriptional
regulation have. These data suggest that allelic expression differences result from the cumulative contribution of
multiple DNA sequence polymorphisms, with each having a small effect, and that allele-specific expression can thus be
viewed as a complex trait.
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Introduction
Allele-speciﬁc expression differences can be identiﬁed by
comparing the relative levels of exonic single nucleotide
polymorphism (SNP) alleles within mRNA samples isolated
fromunrelatedindividuals [1–7].Bothcis- andtrans-regulatory
polymorphisms contribute to differential allelic expression
[6,8,9]. Cis-regulatory polymorphisms are in close proximity to
the gene being regulated and directly affect the transcription
initiation, transcription rate, or transcript stability in an
allele-speciﬁc manner. In contrast, trans-regulatory polymor-
phisms are not in close physical proximity to the gene being
regulated and modify either the expression level or activity of
a factor that interacts with cis-regulatory sequences. Within an
individual mRNA sample, alleles are exposed to the same
cellular environment, and thus their differential expression
must be due to cis-regulatory polymorphisms, whether or not
trans-regulatory polymorphisms also play a role.
Patterns of differential allelic expression in mRNA samples
isolated from unrelated individuals can reveal underlying
regulatory mechanisms [10]. When allelic expression differ-
ences are strongly inﬂuenced by trans-regulatory polymor-
phisms, one exonic SNP allele will be expressed at a higher
level in some heterozygous individuals while in different
individuals the other exonic SNP allele will be expressed at a
higher level. In contrast, when allelic expression differences
arise primarily from cis-regulatory polymorphism in strong
linkage disequilibrium with a gene, the same exonic SNP
allele will be expressed at a higher level in all heterozygous
individuals.
In a large-scale analysis we previously genotyped approx-
imately 2,000 exonic SNP alleles and measured their relative
expression levels using oligonucleotide arrays, to identify
genes with differential allelic expression [10]. In that study we
showed that keratin 1 (KRT-1), which belongs to a large family
of intermediate ﬁlament protein genes and is normally
expressed in keratinocytes in the spinous layer of the
epidermis [11,12], has extreme allele-speciﬁc expression
differences in human white blood cells. Unrelated individuals
in the study heterozygous for a selected KRT1 exonic SNP
allele all had the same allele expressed at a higher level,
suggesting that the differential allelic expression of KRT1 is
predominantly controlled by cis-regulatory polymorphism(s)
in strong linkage disequilibrium with the gene.
In this study we set out to analyze the cis-regulatory
polymorphisms responsible for the expression differences of
the KRT1 alleles in detail. We performed a large number of
experimental assays to identify and characterize SNP alleles in
a previously deﬁned 26-kb KRT1 haplotype block that have
differential regulatory functions. We found ﬁve cis-regulatory
sequences which contain SNP alleles that differ in their
afﬁnity to bind transcription factors and modulate KRT1
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molecular analysis of multiple cis-regulatory sequences whose
combined effects are responsible for differential expression of
two alleles. The results suggest that the cis-regulation under-
lying such expression differences can be highly complex.
Results
Differential Expression of KRT1 in Human White Blood
Cells
As KRT1 has not previously been reported as expressed in
white blood cells, we conﬁrmed our original oligonucleotide
array results [13] by using real-time PCR to analyze the
relative expression levels of the KRT1 alleles in mRNA
extracted from the white blood cells of 36 unrelated
individuals. 19 of the samples were heterozygous for the
assayed exonic SNP2 in KRT1 (Figure 1A). Of these, 15 had
detectable levels of mRNA and could therefore be used to
ascertain relative allelic expression levels (Table 1). In each of
the 15 samples the A exonic SNP2 allele was expressed at a
higher level than the G exonic allele, and in the majority of
samples the expression ratio of A to G was extreme (greater
than 8-fold) (Table 1). This consistent expression of the A
allele over the G allele suggests that the relative expression
levels of the KRT1 alleles in white blood cells are determined
by cis-acting factors in strong linkage disequilibrium with the
assayed exonic SNP.
Haplotype Map Construction and Haplotype Patterns in
the KRT1 Block
To identify possible cis-regulatory polymorphisms we ﬁrst
identiﬁed SNPs in the KRT1 interval on human Chromosome
12 in linkage disequilibrium with the exonic SNP assayed for
differential expression (Figure 1A). To do this we used a
comprehensive genome-wide SNP and haplotype map gen-
erated by an independent study using ethnically-diverse
Coriell samples from the DNA Polymorphism Discovery
Resource as previously described [14]. This map showed that
KRT1 is located entirely within a 26-kb haplotype block
(Figure 1A), which also contains eight of the nine exons of the
KRT1B gene. KRT1B is a newly identiﬁed closely related
paralog of human KRT1 consisting of a similar nine-exon
structure that has not yet been functionally characterized
[15]. The 29 identiﬁed SNPs (Table S1) located within the
KRT1 haplotype block fell into nine haplotype patterns in the
Coriell samples (Table S2). One group of four haplotype
patterns were minor variants of each other and a separate
group of two haplotype patterns were also minor variants of
each other. When haplotype patterns with only minor
variations were grouped together, the number of observed
haplotype patterns in the Coriell samples was reduced to ﬁve.
82% of the chromosomes fell into three of the ﬁve main
haplotype patterns.
KRT1 Haplotype Patterns in the 36 White Blood Cell
Samples
To determine the relationship between the haplotype
patterns and the relative expression levels of the different
KRT1 alleles we determined the haplotype patterns in the 36
white blood cell samples by genotyping seven SNPs (SNPs 2, 5,
6, 11, 17, 23, and 28) that together differentiate the ﬁve main
KRT1 haplotypes (Table 2), using real-time PCR. Only four of
the ﬁve main haplotype patterns present in the Coriell
samples were also present in the white blood cell samples.
The three most prevalent haplotype patterns observed in the
Coriell samples (Table S2) were also the three most prevalent
in the 36 white blood cell samples (Table 3). However, the
relative frequencies of the haplotypes differ between the two
donor populations, suggesting that the ethnic compositions
of the two groups differ.
The 15 samples that were heterozygous for exonic SNP2
and had detectable levels of KRT1 mRNA all contained the
same two haplotype patterns: pattern number 1, which has
the G allele at exonic SNP2, and pattern number 2, which has
the A allele at exonic SNP2 (Table 1). In each of these
samples, haplotype pattern 2 was expressed at much higher
levels than haplotype pattern 1, and thus we deﬁned
haplotype pattern 1 as the low-expressing haplotype pattern
and haplotype pattern 2 as the high-expressing haplotype
pattern. In contrast, the four samples heterozygous for exonic
SNP2 that did not express KRT1 contained haplotype
patterns 1 and 3. These data suggest that in human white
blood cells KRT1 haplotype pattern 2 is expressed at
signiﬁcantly higher levels than haplotype patterns 1 or 3.
We were unable to examine the relative expression levels of
haplotype patterns 4 and 5 due to the fact that in this
population the only individual containing pattern 4 was not
heterozygous for KRT1 exonic SNP2 and pattern 5 was not
observed. The high number of white blood cell samples
heterozygous for haplotype patterns 1 and 2 is expected,
given the high frequencies of the two patterns in this
population: 37.5% and 50%, respectively.
Identification of Protein-Binding SNP Intervals
To identify the cis-regulatory polymorphisms responsible
for the extreme allele-speciﬁc expression differences of the
KRT1 gene, we focused on the SNPs that differentiate the
low- and high-expressing haplotype patterns. Of the 29 SNPs
in the KRT1 block interval, 19 differ between the low- and
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Synopsis
Despite the fact that all humans share nearly identical DNA
sequences, individuals exhibit tremendous variation in heritable
traits, such as height, weight, and skin texture. Recent evidence
suggests that expression level differences between different copies
(alleles) of a gene contribute to these observed differences in
heritable traits. Currently, the mechanisms underlying allele-
expression level differences are poorly understood. In this report
the authors identified and characterized a set of five single
nucleotide polymorphisms (SNPs) contributing to extreme expres-
sion differences between keratin-1 (KRT1) alleles in humans. Each of
the five SNPs is found in a different regulatory sequence in the
proximity of KRT1. The SNPs cause different copies of the five
regulatory sequences to differ in their affinities to bind transcription
factors controlling KRT1 expression. The extreme KRT1 allele-
expression level differences result from the cumulative contributions
of these five SNPs which are tightly linked and inherited in two
common fixed sets, a low- and a high-expressing set. The study
provides important new insights into the complexities of the
mechanisms underlying allele-expression level differences. These
complexities may explain the difficulties researchers frequently
encounter when trying to discover the ‘‘causative SNP’’ in an
interval identified as associated with an inherited trait in a genetic
study.high-expressing haplotype patterns (Figure 1A). We used
several experimental techniques to identify which of the 19
SNPs, whose alleles differ between the low- and high-
expressing haplotypes, are involved in regulating the differ-
ential expression of these haplotypes. First, we performed
electrophoretic mobility shift assays (EMSAs) to examine the
SNP intervals for effects on DNA-protein interactions. We
incubated nuclear extracts from an epithelial cell line with
25-mer double-stranded oligonucleotide probes containing
the SNPs in the center positions (Table S3). Under stringent
assay conditions only ﬁve of the probes, corresponding to
SNPs 5, 11, 17, 23, and 28, bound proteins (Figure 2A). Four of
these probes showed differential protein binding, with the
high-expressing alleles of SNPs 5 and 23 binding more
protein than the low-expressing alleles, and the low-express-
ing alleles of SNPs 11 and 17 binding more protein than the
high-expressing alleles. These assays were performed three
independent times, with the same relative binding levels
between the low- and high-expressing SNP alleles observed.
TRANSFAC Analysis
To determine if any of the ﬁve SNP-containing intervals
shown by EMSA to bind proteins contain consensus binding
sites, TRANSFAC [16] database searches were performed
using the 25-mer oligonucleotide sequences given in Table S3
and the default values of TFSearch (http://www.cbrc.jp/
research/db/TFSEARCH.html). SNP intervals 11, 17, and 23
were identiﬁed as containing binding sites for Staf (the
Xenopus ortholog of the human ZNF143 protein [17]),
deltaEF1 (which binds the same sequence, CACCTG, as the
human homolog ZEB [18,19]), and AML-1a [20], respectively.
These factors all had threshold scores   90.9 with either the
high or low-expressing oligonucleotide sequences and were
the only factors whose binding site included the SNP allele.
ZNF143 is a transcriptional activator [17,21], while ZEB is a
negative regulator of many genes [18,22,23], and AML-1
regulates the expression of genes both negatively and
positively [24–26]. Although none of these transcription
Figure 1. The KRT1 Haplotype Block
(A) The locations of the KRT1 and KRT1B genes and each of the 29 SNPs (represented by a tick mark) are shown, with the SNPs discussed in detail
numbered. The SNP alleles of the high- (H) and low- (L) expressing haplotypes are shown, with the 19 SNPs that differ between the two haplotypes
highlighted. The exonic SNP (number 2) assayed for differential allelic expression is blue; those shown by transient expression assay to enhance or
repress KRT1 promoter activity are green and red, respectively; and the rest are dark gray.
(B) Results from the functional tests for five of the SNPs are summarized. The relative strength of protein binding by the low- and high-expressing SNP
alleles is indicated by symbols (., ,,o r¼). Similarly, the symbols (., ,,o r¼) indicate the relative degree of increased or decreased KRT1 promoter
activity of the low- and high-expressing SNP constructs. The diagram depicts that cis-regulatory SNPs 5 and 23 bind activators (green) as evidenced by
increased KRT1 promoter activity over control constructs, and cis-regulatory SNPs 11, 17, and 28 bind repressors (red) as evidenced by decreased KRT1
promoter activity compared with control constructs. When differential binding or activity is observed, the activators have higher affinity to SNP alleles in
the high-expressing haplotype (H), while the repressors have higher affinity to SNP alleles in the low-expressing haplotype (L). The names of proteins
with consensus binding sites in the SNP-containing intervals are given.
DOI: 10.1371/journal.pgen.0020093.g001
Table 1. Ratio of KRT1 Exonic SNP2 Allele Frequencies in
Heterozygote White Blood Cell Samples as Determined by Real-
Time PCR
White Blood Cell Sample Number Allele Ratio
a
11 0
63
75
11 8
17 7
18 27
19 20
27 21
28 9
29 18
30 19
31 19
34 15
35 11
36 8
aRatio of A allele frequency/G allele frequency for the KRT1 exonic SNP2
DOI: 10.1371/journal.pgen.0020093.t001
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Allele-Specific KRT1 Expressionfactors have previously been shown to regulate expression of
KRT1, ZEB interacts with a co-repressor CtBP [18], which is
knowntorepressthetranscriptionofmanyepithelialgenes[27].
Specific DNA-Protein Interactions for SNP17 and SNP23
Intervals
The availability of antibodies speciﬁc to ZEB and AML-1
allowed us to further examine DNA-protein interactions of
the intervals for SNP17 and SNP23. Pre-incubating the
epithelial cell line nuclear extract with unlabeled SNP17 or
SNP23 competitor oligonucleotides before adding the corre-
sponding biotin-labeled oligonucleotide probes abolished the
observed DNA-protein complexes, indicating that they are
formed by speciﬁc protein-DNA binding interactions (Figure
2B). Simultaneously incubating epithelial cell nuclear extract
with the biotin-labeled oligonucleotide and speciﬁc anti-
bodies for ZEB-1 produced a supershifted band for SNP17.
This supershifted band was observed with the use of two
distinct anti-ZEB antibodies, but was not seen when anti-AML
Table 2. KRT1 Interval SNP Genotypes in the 36 White Blood Cell Samples
White Blood Cell
Sample Number
SNP2
a,b SNP5
a SNP6
a SNP11
a SNP17
a SNP23
a SNP28
a Haplotype
Pattern Number
c
Class
d
1 A GT C T G T CA GA CA C1 / 2 Heterozygous high/low
2 AA CC GG CC AA AA AA 2/2 Homozygous high
3 GG TT TT TT GG CC CC 1/1 Homozygous low
4 AA CC TG TC AG AC AC 2/3 Heterozygous
5 AA CC GG CC AA AA AA 2/2 Homozygous high
6 A GT C T G T CA GA CA C1 / 2 Heterozygous high/low
7 A GT C T G T CA GA CA C1 / 2 Heterozygous high/low
8 AA CC GG CC AA AA AA 2/2 Homozygous high
9 GG TT TT TT GG CC CC 1/1 Homozygous low
10 AA CC GG CC AA AA AA 2/2 Homozygous high
11 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
12 GG TT TT TT GG CC CC 1/1 Homozygous low
13 AA CC TG TC AG AC AC 2/3 Heterozygous
14 AA CC TG CC AA AA AC 2/4 Heterozygous
15 AA CC TG TC AG AC AC 2/3 Heterozygous
16 AA CC GG CC AA AA AA 2/2 Homozygous high
17 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
18 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
19 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
20 AG TC TT TT GG CC CC 1/3 Heterozygous
21 AG TC TT TT GG CC CC 1/3 Heterozygous
22 AG TC TT TT GG CC CC 1/3 Heterozygous
23 GG TT TT TT GG CC CC 1/1 Homozygous low
24 AA CC GG CC AA AA AA 2/2 Homozygous high
25 AG TC TT TT GG CC CC 1/3 Heterozygous
26 AA CC GG CC AA AA AA 3/3 Homozygous high
27 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
28 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
29 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
30 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
31 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
32 AA CC TG TC AG AC AC 2/3 Heterozygous
33 AA CC GG CC AA AA AA 2/2 Homozygous high
34 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
35 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
36 AG TC TG TC AG AC AC 1/2 Heterozygous high/low
aThe seven SNPs assayed here together differentiate between the five major KRT1 block haplotype patterns. The full haplotype patterns are shown in Table S2.
bSNP2 is the exonic SNP assayed for differential allelic expression.
cHaplotype pattern 1 corresponds to the low-expressing haplotype, and haplotype pattern 2 corresponds to the high-expressing haplotype, as determined by expression levels of SNP2 in
the 36 white blood cell samples.
dThe 15 samples in bold font are heterozygous for the high- and low-expressing haplotypes and were assayed for differential expression.
DOI: 10.1371/journal.pgen.0020093.t002
Table 3. Frequency of KRT1 Block Haplotype Patterns in the 36
White Blood Cell Samples
Haplotype
Pattern Number
Frequency
(%)
Haplotype Tagging SNP Number
a
N2
b 5 6 11 17 23 28
1 (Low
c) 37.5 G T T T G C C
2 (High
c)5 0 A C G C A A A
31 1 A C T T G C C
4 1.4 A C T C A A C
5 0.0 A T T T G C C
aThe seven SNPs assayed here are KRT1 haplotype block tagging SNPs that together
differentiate between the five major haplotype patterns. The full haplotype patterns are
shown in Table S2.
bSNP2 is the exonic SNPs assayed for differential allelic expression.
cHaplotype pattern 1 is the low-expressing haplotype and haplotype pattern 2 is the high-
expressing haplotype, as determined by expression levels of SNP2 in the 36 white blood
cell samples.
DOI: 10.1371/journal.pgen.0020093.t003
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Allele-Specific KRT1 Expressionor anti-RXR antibodies were used, suggesting that the SNP17
interval binds speciﬁcally to ZEB.
Chromatin immunoprecipitation assays showed a clear
enrichment of the SNP17 interval with anti-ZEB immuno-
precipitates compared with mock immunoprecipitates
(Figure 2C), although binding with anti-AML-1 immunopre-
cipitates is also seen. The fact that protein-DNA interactions
between SNP17 interval and AML-1 are not observed in the
supershift assay but appear to be present in the immunopre-
cipitation assay is likely due to that fact that the former uses a
DNA interval (25 bp) centered on SNP17 while the later
ampliﬁes a 475-bp interval (Table S4) surrounding SNP17.
TRANSFAC analysis of this 475-bp sequence shows the region
contains a predicted AML-1 binding site 205 bp away from
SNP17. Thus, the enrichment of the SNP17 interval with anti-
AML-1 immunoprecipitates over mock immunoprecipitates
may be due to speciﬁc protein-DNA interactions. In
aggregate, the TRANSFAC search data, the supershift assay
results, and the immunoprecipitate data supports in vivo
binding of ZEB to the SNP17 interval.
For the SNP23 interval, simultaneously incubating epithe-
lial cell nuclear extract with the biotin-labeled oligonucleo-
tide and antibodies speciﬁc for AML-1 produced a
supershifted band (Figure 2B), which is slightly more
prominent than the background smear in the same location
observed without antibodies and with antibodies speciﬁc for
ZEB. The chromatin immunoprecipitation assays showed a
modest enrichment of the SNP23 interval with anti-AML-1
compared with mock and anti-ZEB immunoprecipitates
(Figure 2C). These data provide supporting evidence to the
TRANSFAC search data, suggesting that the SNP23 interval
binds in vivo with AML-1.
Due to the lack of an appropriate antibody for ZNF143, we
were unable to use similar techniques to analyze the SNP11
interval for DNA-protein interactions.
Functional Characterization of cis-Regulatory SNP Intervals
To examine how the ﬁve SNP-containing intervals shown
by EMSA to bind proteins affect in vivo KRT1 promoter
expression, we generated a series of 20 luciferase reporter
Figure 2. DNA-Protein Binding Studies
(A) EMSA analyses for SNPs 5, 11, 17, 23 and 28. Lane 1 shows the high-expressing oligonucleotide incubated without nuclear extract. Lanes 2 and 3
show the high- and low-expressing SNP allele oligonucleotides, respectively, incubated with nuclear extract.
(B) Competitor studies and antibody-mediated supershift assays. Biotin-labeled oligonucleotides corresponding to the 25-bp sequences immediately
surrounding SNPs 17 and 23 were incubated with (þ) or without ( ) nuclear extract (NE), 100-fold excess unlabeled oligonucleotide competitor (Comp.),
and the specific antibodies (Ab) indicated.
(C) PCR assays with primer pairs specific for the SNP17 and SNP23 intervals and DNA that was immunoprecipitated with antibodies against ZEB and
AML-1 or mock immunoprecipitated without antibody (No Ab), with anti-rabbit IgG only, or with antibody against retinoid X receptor (RXR). Positive
controls consisting of 1 ng, 10 ng, and 100 ng of whole lysate DNA were amplified in parallel.
DOI: 10.1371/journal.pgen.0020093.g002
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Allele-Specific KRT1 Expressionconstructs, in which SNP intervals were attached to the KRT1
promoter, and performed transient expression studies. The
constructs consisted of the low- and high-expressing KRT1
promoters alone (numbers 1–2 in Figure 3) and combined
with one of nine SNP intervals (containing either the low- or
high-expressing alleles): the protein-binding SNPs 5, 11, 17,
23, and 28 (numbers 3–12 in Figure 3) or control SNPs 7, 14,
22, and 27 (numbers 13–20 in Figure 3). The promoter
sequences examined were ; 600 bp in length and the SNP
intervals averaged ; 350 bp in length (Table S4). The control
SNP alleles were chosen because they differ between the low-
and high-expressing haplotypes but did not bind protein
under stringent conditions in the EMSA assay. The construct
containing the high expressing version of the KRT1 promoter
alone was used as a control against which the expression
levels of all the other constructs were compared. 15%
changes in expression compared with the high-expressing
KRT1 promoter alone equal 2 standard deviations and thus
are signiﬁcant (p ¼ 0.05).
We ﬁrst determined whether the activities of the paired
low- and high-expressing constructs were different from one
another. The activities of the two constructs containing the
low- and high-expressing KRT1 promoters alone were not
signiﬁcantly different from one another (numbers 1–2 in
Figure 3). Likewise, the activities of the paired low- and high-
expressing constructs containing control SNPs 7, 14, 22, and
27 (numbers 13–20 in Figure 3) were similar to each other.
The activities of two of the paired low- and high-expressing
constructs containing protein-binding SNPs 5 and 11
(numbers 3–6 in Figure 3) are similar to each other. However,
the activities of the other three paired low- and high-
expressing constructs containing protein-binding SNPs 17,
23, and 28 (numbers 7–12 in Figure 3) are different from one
another by 14%, 18%, and 23%, respectively. These data
suggest that the low- and high-expressing intervals containing
SNPs 17, 23, and 28 have different afﬁnities for transcrip-
tional regulators.
We then compared the activities of the low- and high-
expressing constructs to the activity of the high-expressing
KRT1 promoter alone. The activities of the low- and high-
expressing constructs containing control SNPs 7, 22, and 27
were only 2%–8% different from the activity of the KRT1
promoter alone (numbers 13–14 and 17–20 versus 1 in Figure
3). The activities of the low- and high-expressing constructs
containing control SNP14 (numbers 15–16 versus 1 in Figure
3) were both approximately 15% different from the KRT1
promoter alone. These data suggest that when a random
sequence interval of ; 350 bp is inserted in front of the KRT1
promoter, the majority of the time the construct will not have
signiﬁcantly increased activity.
The activities of all ﬁve pairs of low- and high-expressing
constructs containing protein-binding SNPs were signiﬁ-
cantly different from the KRT1 promoter alone (numbers 3–
12 versus 1 in Figure 3). The constructs containing SNPs 11,
17, and 28 intervals have signiﬁcantly less activity than the
KRT1 promoter alone. The activities of the low- and high-
expressing SNP11 interval constructs were both approxi-
mately 30% less than that of the KRT1 promoter alone. The
activity of the low-expressing SNP17 interval construct was
29% less, while the high-expressing construct was 15% less
than the KRT1 promoter alone. The activity of the low-
expressing SNP28 interval was 42% less while the high-
Figure 3. Transient Expression Assays
Luciferase reporter constructs containing either the low (L) or the high
(H)-expressing KRT1 promoter (PRHo rL ) or the promoter combined with
SNP-containing interval(s) are shown on the left (numbered 1–26).
Relative KRT1 promoter activity of constructs 2–26 is expressed in %
versus control construct PRH (assay 1). The relative luciferase activities
represent the mean 6 standard deviation of two to three independent
experiments performed in triplicate or quadruplicate. Double-stranded
decoy oligonucleotides, O17Ho rLand O28Ho rL(sequences shown at
bottom), co-transfected with the KRT1 promoter alone and in various
combinations with the H and L SNP17 and SNP28; constructs are shown
for numbers 27–38. The relative KRT1 promoter activity of constructs 28–
32 is expressed in % versus control construct 27, the relative activity for
constructs 34–38 is expressed in % versus control construct 33.
DOI: 10.1371/journal.pgen.0020093.g003
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Allele-Specific KRT1 Expressionexpressing construct was 19% less than the KRT1 promoter
alone. These data suggest that the intervals containing SNPs
11, 17, and 28 bind transcriptional inhibitors, with the low-
expressing SNP17 and SNP28 sequences having a higher
afﬁnity for the inhibitors than the corresponding high-
expressing intervals.
The constructs containing SNPs 5 and 23 have signiﬁcantly
greater activity than the KRT1 promoter alone. The activities
of the low- and high-expressing SNP5 interval constructs
were both approximately 35% greater than that of the KRT1
promoter alone. The activity of the high-expressing SNP23
interval construct was 38% greater while the low-expressing
construct was 20% greater than the KRT1 promoter alone.
These data suggest that the sequences in the SNPs 5 and 23
intervals bind transcriptional activators, with the high-
expressing SNP23 sequence having a higher afﬁnity for the
activator than the low-expressing SNP23 sequence.
Interactions of SNP Regulatory Intervals
Next we examined whether combining the SNP17 and
SNP28 intervals into a single construct would result in a
greater decrease in activity of the KRT1 promoter than either
interval alone. We chose to examine these two SNP intervals
because they both bind transcriptional inhibitors, and the
activities between the paired low- and high-expressing
constructs are signiﬁcantly different. Two additional con-
structs were generated, with the low-expressing SNP17 and
SNP28 intervals combined with the low-expressing KRT1
promoter and the high-expressing SNP17, and SNP28
intervals combined with the high-expressing KRT1 promoter
(numbers 21–22 in Figure 3). The combined low-expressing
construct had 53% less activity than the KRT1 promoter
alone, which is 24% and 11% less activity than the low-
expressing SNP17 and SNP28 constructs (numbers 22, 8, 12
versus 1 in Figure 3, respectively). And the combined high-
expressing construct had 24% less activity than the KRT1
promoter alone, which is 10% and 5% less activity than the
high-expressing SNP17 and SNP28 constructs (numbers 21, 7,
11 versus 1 in Figure 3, respectively). Thus, when the SNP17
and SNP28 intervals are combined in a single construct, the
KRT1 promoter activity is repressed to a greater extent than
that observed for either interval alone.
Although the two constructs containing either the low- or
high-expressing KRT1 promoters alone were similar in
activity, we reasoned that variants in the promoter interval
could be interacting with the protein-binding SNP intervals.
To examine this possibility, we generated four additional
constructs with the low-expressing KRT1 promoter combined
with the high-expressing SNP17 or SNP28 intervals and the
high-expressing KRT1 promoter combined with the low-
expressing SNP17 and SNP28 intervals (numbers 23–26 in
Figure 3). The high-expressing promoter combined with the
low-expressing SNP17 or SNP28 intervals had respectively
3% and 19% greater activity than the low-expressing
promoter combined with these same intervals (numbers 23
versus 8, and 25 versus 12 in Figure 3). Whereas the constructs
containing the low-expressing promoter combined with the
high-expressing SNP17 or SNP28 intervals both had respec-
tively 10% and 18% less activity then the high-expressing
promoter combined with the same intervals (numbers 24
versus 7, and 26 versus 11 in Figure 3). These data suggest that
the degree of transcriptional repression is dependent on
interaction between the repressors binding to the SNP
intervals and the KRT1 promoter itself, with the low-
expressing version of the promoter producing a greater
inhibitory effect. Thus, polymorphisms in the promoter
interval, such as SNP9 and SNP10 (Figure 1), as well as other
variants not yet identiﬁed, may also play a role in the
differential expression of KRT1 low- and high-expressing
haplotypes.
Decoy Oligonucleotides
To conﬁrm that the inhibitory effects of the ; 350-bp
SNP17 and SNP28 intervals were due to sequences containing
the SNPs, we performed double-stranded DNA decoy
oligonucleotide assays [28]. When double-stranded DNA
decoy oligonucleotides are transfected into cells they com-
pete with regulatory sequences for binding transcription
factors and therefore enhance or reduce transcriptional
activation. The decoy oligonucleotides, O17H, O17L, O28H,
and O28L, used to compete with the SNP17 and SNP28
reporter constructs for transcriptional factors, are shown in
Figure 3. The activity of the construct containing the high-
expressing version of the KRT1 promoter alone co-trans-
fected with decoy oligonucleotide O17H (number 27 in Figure
3), was used as the control against which the expression levels
of SNP17 interval-containing constructs were compared
(numbers 28–32 in Figure 3). The activity of this same
construct co-transfected with decoy oligonucleotide O28H
(number 33 in Figure 3) was used as the control against which
the expression levels of SNP28 interval-containing constructs
were compared (numbers 34–38 in Figure 3). Co-transfection
of SNP17 and SNP28 decoy oligonucleotides with their
corresponding constructs (numbers 29–30 and 35–36 in
Figure 3) reversed the inhibitory effects of these intervals
on the KRT1 promoter activity (numbers 7–8 and 11–12 in
Figure 3). These results imply that the 25-bp regions
immediately surrounding SNPs 17 and 28 are responsible
for the observed inhibitory effects of the SNP17 and SNP28
intervals on the KRT1 promoter activity.
Interestingly, the low-expressing SNP17 construct co-
transfected with the low-expressing SNP17 allele decoy had
31% greater activity than the control (number 27 versus 30 in
Figure 3). When the low-expressing SNP17 allele decoy was
co-transfected with the high-expressing construct, and vice
versa (numbers 31–32 in Figure 3), the high-expressing
construct had 52% greater activity than the control. These
data indicate that the low-expressing SNP17 decoy binds the
transcriptional repressor more tightly than the high-express-
ing SNP17 decoy. The observed increased activity of the
SNP17 constructs in the presence of the O17L compared with
the control is surprising. One explanation for these results is
that if the repressor does not bind to the 475-bp SNP17
interval (Table S4), then a binding site for a transcriptional
activator becomes available or a DNA conformation change
occurs, resulting in an enhancement of the KRT1 promoter
activity. When the low-expressing SNP28 allele decoy was co-
transfected with the high-expressing construct, and vice versa
(numbers 37–38 in Figure 3), the high-expressing construct
had 17% greater activity and the low-expressing construct
had 17% decreased activity compared with the control. These
data are consistent with the results observed for the SNP17
decoy tests, suggesting that the low-expressing SNP28 decoy
binds a repressor more tightly than the high-expressing
PLoS Genetics | www.plosgenetics.org June 2006 | Volume 2 | Issue 6 | e93 0854
Allele-Specific KRT1 Expressiondecoy, and that by preventing the repressor from binding the
414-bp SNP28 interval allows for the binding of an activator
or a DNA conformation change, and thus increased construct
activity over the control.
Comparative Sequence Analysis of the 26-Kb KRT1
Haplotype Block
To further characterize the intervals containing the ﬁve cis-
regulatory SNPs we performed a comparative analysis
between human and mouse sequences to determine if they
are evolutionarily conserved. We obtained the nucleotide
sequence of the 26-kb KRT1 haplotype and aligned it to the
orthologous mouse interval using VISTA browser (http://
pipeline.lbl.gov/cgi-bin/gateway2). The alignment of the hu-
man and mouse intervals revealed 35 conserved sequences ( 
100 nucleotides in length and   70% identity). Of these 35
conserved sequences in the 26-kb haplotype block, 19 overlap
exons or UTRs from KRT1 and KRT1B, and 16 are present in
non-coding regions. Considering all 29 SNPs in the 26-kb
KRT1 interval, four occur within the 35 conserved sequences
(SNPs 2, 12, 18, and 28) (Figure 1). Two of these are present in
protein-encoding sequences (SNP2 resides in exon 9 of
human KRT1 and SNP28 resides in exon 2 of human KRT1B),
and the other two (SNP12 and SNP18) are in conserved non-
coding sequences. SNPs 12 and 18 have the same alleles in the
KRT1 low- and high-expressing haplotype patterns, and
therefore are not likely to be involved in KRT1 differential
allelic expression. It is interesting to note that the SNP28
interval appears to have dual functions as both a transcrip-
tional regulatory sequence inhibiting KRT1 promoter activity
and an exonic sequence in the KRT1B gene [15]. The other
four cis-regulatory SNPs, SNP5, SNP11, SNP17, and SNP23,
are in sequences that are not evolutionarily conserved
between human and mouse.
We aligned the cis-regulatory SNP intervals and the exonic
SNP2 sequence to the chimpanzee genomic intervals to
determine which allele (the low- or high-expressing) reﬂects
the ancestral sequence. Four of the cis-regulatory SNP
intervals containing SNPs 5, 11, 17, and 28 could be aligned
unambiguously to chimpanzee sequences, in each case the
SNP allele with the lower afﬁnity for the transcription factor
was the derived one. Thus, the high-expressing SNP5 allele
and the low-expressing SNP11, SNP17, and SNP28 alleles
were the ancestral ones. The high-expressing exonic SNP2
was the ancestral sequence. Based on these data, both the low-
and high-expressing haplotypes are derived, and haplotype
pattern 3 (Table 3) is the ancestral one.
Discussion
Our aim was to discover and characterize the regulatory
sequences responsible for the extreme allele-speciﬁc expres-
sion differences of KRT1 in human white blood cells. In all
individuals expressing KRT1 and heterozygous for exonic
SNP2, the same allele is always expressed at a signiﬁcantly
higher level then the other allele. These data suggest that the
KRT1 allelic-expression differences likely result primarily
from cis-regulatory polymorphisms in strong linkage disequi-
librium with exonic SNP2. We determined that all nine KRT1
exons as well as ;22 kb of sequences upstream of the gene are
contained within a single haplotype block. The high-express-
ing KRT1 exonic SNP2 allele maps to haplotype pattern 2,
while the low-expressing SNP2 allele maps to haplotype
pattern 1, suggesting that cis-regulatory variants differing
between these two haplotypes are likely responsible for the
majority of the allele-speciﬁc expression differences.
Examining SNPs whose alleles differ between the low- and
high-expressing KRT1 haplotypes using a variety of exper-
imental and computational methods, we identiﬁed ﬁve cis-
regulatory polymorphisms. SNP5 and SNP23 cis-regulatory
intervals act as positive regulators of the KRT1 promoter in
luciferase reporter assays, while SNP11, SNP17, and SNP28
cis-regulatory intervals act as negative regulators. Consistent
with these data is the fact that SNP11 and SNP17 are present
in predicted binding sites for ZNF143 and ZEB, respectively;
both known to act as negative transcriptional regulators. And
SNP23 is present in a predicted binding site for AML-1, a
known positive transcriptional regulator. EMSA and chro-
matin immunoprecipitation assays suggest that ZEB and
AML-1 respectively bind the SNP17 and SNP23 intervals in
vivo.
Our study shows that the extreme allele-speciﬁc expression
differences of KRT1 result from the haplotypic combinations
of the ﬁve cis-regulatory polymorphisms that differ between
the low- and high-expressing patterns. The high-expressing
alleles of SNP5 and SNP23 bind more protein in the EMSA
than the low-expressing allele. In addition, the high-express-
ing SNP23 allele exhibited an almost 2-fold increase in the
KRT1 promoter activity compared with the low-expressing
allele in the luciferase reporter assay. Thus, for both SNP5
and SNP23 the high-expressing alleles appear to have higher
afﬁnities for transcriptional activators than the low-express-
ing alleles. On the other hand, the low-expressing alleles of
SNP11 and SNP17 bind more protein in EMSA than the high-
expressing allele. In the luciferase reporter assays the low-
expressing SNP17 and SNP28 constructs have approximately
2-fold less KRT1 promoter activity then the high-expressing
allele constructs. Thus, our data indicate that for SNP11,
SNP17, and SNP28 the low-expressing alleles have higher
afﬁnities for transcriptional repressors than the high-ex-
pressing alleles. Additionally, when combined, the SNP17 and
SNP28 intervals result in a greater reduction of KRT1
promoter activity then that observed for either interval
alone. And interactions between the individual SNP17 and
SNP28 intervals with the KRT1 promoter(s) suggest that there
are functional polymorphisms in the promoter region
resulting in less activity for the low-expressing version. It is
important to note that in addition to these functional
promoter variants other cis-regulatory polymorphisms may
exist in the KRT1 haplotype block and/or adjacent haplotype
blocks that are also involved in the extreme differential KRT1
allelic expression. However, the haplotypic combinations of
the ﬁve cis-regulatory polymorphisms that we identiﬁed and
characterized in this study can readily explain a large fraction
of the observed allele-speciﬁc KRT1 expression differences.
Previous studies examining allele-speciﬁc expression dif-
ferences have focused on analyzing single SNPs or SNPs
grouped in a short interval, such as a promoter [29–34]. Thus,
our study provides important new insights into the complex-
ities of the molecular mechanisms underlying allele-expres-
sion differences. The fact that each of the ﬁve cis-regulatory
SNPs we characterized contributes to just a fraction of the
observed variation indicates that allele-speciﬁc expression is
itself a complex trait. Interestingly, the ﬁnding that allelic-
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multiple cis-regulatory SNPs may explain the difﬁculties
researchers frequently encounter when trying to discover
the ‘‘causative SNP’’ underlying a linkage peak or in an
interval identiﬁed as associated with a trait in a genetic study.
It is generally well proven that non-coding sequences
conserved between humans and mice can represent func-
tional regulatory elements [35–37]. However, in a previous
study we demonstrated that functional cis-regulatory sequen-
ces in humans can be missing in other mammals, even closely
related primate species [38]. Based on functional data in this
study we proposed that this class of cis-regulatory sequences
represent rapidly evolving elements that are responsible for
gene expression differences between species. Since the cis-
regulatory SNPs identiﬁed here are involved in intra-species
gene regulatory differences, the fact that four of the intervals,
SNP5, SNP11, SNP17, and SNP23, are not evolutionarily
conserved between humans and mice is consistent with our
previous observations and hypothesis. The fact that the
SNP28 interval appears to have dual functions as a cis-
regulatory sequence and an exonic sequence in the KRT1B
gene raises the possibility that transcription of the KRT1 and
KRT1B genes is linked by a novel mechanism.
KRT1 has not previously been shown to have a functional
role in white blood cells, and hence we are unable to state
whether or not the observed expression differences between
the low-expressing and high-expressing haplotype patterns
have physiological relevance. Interestingly, a recent study
indicates that allele-speciﬁc expression differences observed
in white blood cells can be associated with physiological
relevance in other tissues [39]. The investigators of this study
identiﬁed two genes with allelic-expression differences in
white blood cells isolated from osteoarthritis patients and
those isolated from control individuals, and they also showed
that these same two genes contain 59 SNPs with statistically
signiﬁcant association with osteoarthritis. KRT1 is expressed
in the basal layer of the epidermis and plays a major role in the
differentiation and function of keratinocytes [11]. KRT1
expression is down-regulated in keratinocytes in response to
wounding [40,41]. This down-regulation of KRT1 expression is
thought to be necessary for keratinocytes to make the
morphological changes required for migration [40,41] into
the wound site. Based on the functional role of KRT1 it is
interesting to hypothesize that the allele-speciﬁc expression
differences observed in human white blood cells may be
associated with keratinocyte migration rates in response to
wounding. In theory, if keratinocytes homozygous for the low-
expressing haplotype pattern down-regulate KRT1 expression
more quickly than those homozygous for the high-expressing
pattern, they should migrate sooner in response to wounding.
Materials and Methods
Isolation of DNA and RNA from white blood cell samples. Thirty-
six anonymous individuals were randomly selected at the Stanford
Blood Center (Palo Alto, California, United States). White blood cells
were isolated from 35–37 ml buffy-coats (white blood cell-enriched
blood samples) by centrifugation in Ficoll density medium (Amer-
sham Pharmacia, Little Chalfont, United Kingdom). RNA and DNA
were puriﬁed using Trizol Reagent (Invitrogen, Carlsbad, California,
United States) according to the manufacturer’s instructions. Each
sample yielded between 200 lg 400 lg of RNA and ; 1 mg of DNA.
The RNA was treated with DNase I, puriﬁed again by phenol-
chloroform extraction and ethanol precipitated. cDNA was generated
by reverse transcription of the RNA using SuperscriptII RT
(Invitrogen) in the presence of random hexamers, followed by
RNaseH treatment to eliminate the RNA. Both DNA and cDNA were
diluted to 20 ng/ ll for use as templates in PCR reactions.
Differential expression of KRT1 in white blood cell samples. We
used real-time PCR methods described by Germer et al. [42] to
determine whether the KRT1 alleles were differentially expressed in
the white blood cell samples from individuals heterozygous for KRT1
exonic SNP2. We used two allele-speciﬁc forward primers: 59
GTGGCAGTTCCAGCGTGA 39 and 59 GTGGCAGTTCCAGCGTGG
39 with one reverse primer: 59 GCATCTGGTTACTCCGGA 39 in both
combinations (one forward primer per reaction) in separate real-
time PCR reactions. White blood cell samples with a cycle threshold
of greater than 30 were considered to express KRT1 only at
background level.
Characterization of protein-binding SNP intervals. We tested the
19 SNPs (excluding exonic SNP2) that differentiate the low- and high-
expressing KRT1 haplotypes for protein binding by performing
EMSA. 25-mer oligonucleotides containing the SNPs in the center
positions (Table S3) were end-labeled with Biotin-ddUTP by terminal
transferase and puriﬁed by G-25 spin columns (Amersham).
Complementary oligonucleotides were annealed as described pre-
viously [28]. Nuclear extracts from a duodenum epithelial cell line
(HuTu 80) were isolated using the Nuclear Extraction Kit (Pierce
Biotechnology, Rockford, Illinois, United States) according to the
manufacturer’s instructions. We initially tested a subset of the SNP
probes with both stringent (10 mM Tris, 50 mM KCl, 1 mM DTT [pH
7.5], 5 mM MgCl2) [43,44] and non-stringent (10 mM Tris, 50 mM KCl,
1 mM DTT [pH 7.5]) binding-buffer conditions. Under non-stringent
conditions more than half of the probes tested bound protein, while
under stringent conditions we only observed binding to the ﬁve
reported probes. 2 ll (about 8 lg) nuclear protein extract was
incubated with 20 fm biotin-labeled double-stranded oligonucleo-
tides, 1lg poly dI-dC, binding buffer in a 20-ll reaction volume for 20
min at room temperature (Pierce LightShift Chemiluminescent
EMSA kit). The reaction mixture was then analyzed by electro-
phoresis in a non-denaturing 5% acrylamide gel with cold 0.5X TBE
running buffer. The DNA-protein complexes in the gel were then
transferred to positively charged nylon membrane by electrophoretic
transfer in 0.5X TBE at 380 mA for 30–60 min, and detected using the
Light-shift Biotin Detection Kit (Pierce Biotechnology). For com-
petition studies, the nuclear extract was pre-incubated with
unlabeled double-stranded oligonucleotides (100-fold excess) before
adding the biotin-labeled double-stranded oligonucleotides. In the
super-shift assays, 2 lg of antibody [anti-ZEB (C-20), anti-ZEB (E-20),
anti-AML-1 (N-20), and anti-RXR (DN 197)] obtained from Santa
Cruz Biotechnology (Santa Cruz, California, United States) were
incubated with DNA-protein complexes on ice for 2 h before gel
electrophoresis.
Chromatin immunoprecipitation assay. Chromatin immunopreci-
pitation assays were performed using the CHIP Assay Kit according
to the manufacturer’s protocol (Upstate Biotechnology, Lake Placid,
New York, United States) and antibodies obtained from Santa Cruz
Biotechnology. Brieﬂy, 1–2310
7 duodenum epithelial cells (HuTu 80)
were ﬁxed with formaldehyde. After cell lysis, the chromatin was
sheared with a water-bath sonicator at 30% of maximum power for
three 10-s pulses. The cell lysate was then diluted and DNA-protein
complexes were immunoprecipitated by the anti-ZEB (C-20), anti-
ZEB (E-20), anti-AML-1 (N-20), and anti-RXR (DN 197) antibodies.
Immunoprecipitated DNA was analyzed for speciﬁc enrichment by
semi-quantitative PCR using one-third of the eluted material and
primer pairs speciﬁc for the SNP17 and SNP23 intervals. The primer
pairs were as follows: SNP17 forward ACACTGAGCTTGAAGGTCC;
SNP17 reverse CTGGAAACAGTGAAAAGGCTG; SNP23 forward
CCTGGGAACACAGTGTCTTA; SNP23 reverse GGAGAAACT-
GAGCTAGGGAA. 26 PCR cycles were used in the analysis to
determine if AML-1 binds the interval containing SNP23, and 30
cycles were used in the analysis to determine if ZEB binds the interval
containing SNP17.
Generation of luciferase reporter constructs. DNA samples known
to be homozygous for either the high-expressing KRT1 haplotype
(blood sample number 2) or the low-expressing KRT1 haplotype
(blood sample number 3) were used as PCR templates. Ten sets of
PCR primers (Table S4) were used to amplify either the KRT1
promoter or one of the nine SNP intervals examined, from the two
DNA samples. This generated a total of 20 PCR products. The PCR
reactions were carried out in 50-ll reaction volumes with 1X PCR
buffer, 2mM MgCl2, 0.2 mM dNTP, 20 ng DNA, and 5 units of Taq
Gold DNA polymerase. The PCR products were cloned into the TA
cloning vector pCR2.1 (Invitrogen). The KRT1 promoter fragment
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of pGL3-basic vector (Promega, Madison, Wisconsin, United States)
to generate the KRT1 promoter-luciferase reporter constructs,
pGL3- PRH and pGL3- PRL, with H and L being the high-expressing
and low-expressing alleles respectively. The nine other sets of high-
and low-expressing SNP-containing intervals were digested by KpnI
and XhoI from pCR2.1, gel-puriﬁed and ligated into the KpnI and XhoI
sites of the pGL3-PRH and pGL3- PRL promoter constructs in
various combinations to generate SNP region-KRT1 promoter
luciferase reporter constructs pGL3- PH/L SNPnH/L, where n is the
SNP number.
Transfection of luciferase reporter constructs. We transfected each
of the 26 luciferase reporter constructs into a duodenum epithelial
cell line (HuTu80) that was obtained from ATCC (American Type
Culture Collection, Manassas, Virginia, United States) and cultured in
MEM alpha medium supplemented with 10% FBS. Although KRT1 is
not known to be expressed in duodenum epithelial cells under
normal physiological circumstances, the HuTu80 cells are appropri-
ate to use for examining the effect of the SNP alleles in transcrip-
tional regulation using reporter gene assays because they are of
epithelial origin. Approximately 23 10
5 cells/well were seeded in 24-
well cell culture plates 24 h before transfection. The cells were
simultaneously transfected with one of the 30 pGL3-luciferase
reporter constructs (0.8 lg) and a pSV- b-galactosidase control
plasmid (0.2 lg) (Promega) to use as an internal standard for
transfection efﬁciency using 2-ll Lipofectamine reagent (Invitrogen)
according to manufacturer’s instructions. For the decoy oligonucleo-
tide analysis 25 pico-moles of double-stranded O17 or O28 decoy
oligonucleotides were co-transfected with the reporter constructs
[45,46]. After 48 h, the cells were harvested and lysed with reporter
lysis buffer. Luciferase and b-galactosidase expression were assayed
with the Bright-Glo luciferase assay system (Promega) and the
Galactosidase enzyme assay system (Promega), respectively.
Analysis of luciferase reporter constructs. The reporter constructs
containing only the KRT1 promoter region were assayed six
independent times in triplicate. The other 24 reporter constructs
were assayed two or three independent times in triplicate or
quadruplicate. Assays were performed on different days, with the
promoter-only constructs assayed on each occasion. For each
individual transfection the luciferase activity was normalized against
the b-galactosidase activity. To allow comparisons between the assays
performed on different days, we normalized the results from each day
by dividing values for each construct assay by the lowest KRT1
promoter-only construct value. The high-expressing KRT1 promoter
was the control construct that all other constructs were compared
with; its relative luciferase activity was 100% 6 7%, which represents
the mean 6 standard deviation of 18 independent assays.
Comparative sequence analysis. We obtained the nucleotide
sequence of the 26-kb haplotype block on human Chromosome 12
(nucleotides 51, 354, 757–51, 381, 206 from NCBI Build 35) from the
UCSC Genome Browser Gateway (http://genome.ucsc.edu/cgi-bin/
hgGateway). The orthologous mouse interval was identiﬁed on
Chromosome 15, nucleotides 102, 324, 855–102, 346, 822, by aligning
the human Chromosome 12 sequence to mouse genomic sequences
(NCBI Build 33) using VISTA browser (http://pipeline.lbl.gov/cgi-bin/
gateway2). The alignment of the human and mouse intervals revealed
35 conserved sequences (  100 nucleotides in length and   70%
identity).
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